COLL: Collegium Pharmaceutical Inc Earnings per share for the last twelve months

COLL (Collegium Pharma) - company brandmark

Collegium Pharmaceutical (COLL) profitability relies on patent protection and the sale of non-opioid medications. The trailing 12-month earnings per share trend demonstrates financial stability, where the parameter value equals 0.98. Management efficiency is evident in the successful acquisition of niche drugs, while commitment to ESG principles is reflected in strict distribution control and the eco-friendly disposal of chemical waste during production.

COLL (Collegium Pharmaceutical) Net earnings per share for the last 12 months history from 07/04/2022 to 11/14/2026

Collegium Pharma - analytical breakdowns and key metrics (COLL)

- current quotes and average value forecast:
Price Chart Collegium Pharmaceutical|COLL - Fair Value Consensus
- market capitalization information:
Market Value Collegium Pharmaceutical, Inc.|COLL - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Book Value per Share Collegium Pharmaceutical|COLL - Company Net Assets|Market Value to Book Value Ratio collegiumpharma.com|COLL - Company Assets
- debt and liquidity data:
Debt to Equity Collegium Pharmaceutical|COLL - Long-Term Debt to Equity|Short-Term Debt to Equity Collegium Pharmaceutical Inc|COLL - Company Debts|Debts to Book Capitalization Collegium Pharmaceutical, Inc.|COLL - Long-Term Debt|Company Short-Term Debts Collegium Pharmaceutical|Quick Ratio collegiumpharma.com
- net income and valuation multiples indicators:
COLL - Net Financial Result|Future Profit Collegium Pharmaceutical|COLL - P/E Multiple|Future Price to Earnings Collegium Pharmaceutical, Inc.|COLL - Price/Earnings to Growth Multiple|Enterprise Value to EBITDA Ratio Collegium Pharmaceutical, Inc.|COLL - Income before deduction of interest, taxes and amortization|Earnings per share for the last twelve months Collegium Pharmaceutical|COLL - Earnings per one share for the last 12 months|Quarterly EPS earnings growth collegiumpharma.com|COLL - Earnings per share increase in current year|Earnings growth forecast for next year Collegium Pharmaceutical
- revenue and sales details:
COLL - Revenue and Sales Volume|Company Projected Revenue Collegium Pharmaceutical|COLL - Market Capitalization-to-Revenue Ratio|Price-to-Projected Revenue Ratio Collegium Pharmaceutical, Inc.
Fundamental company valuation:Collegium Pharmaceutical (COLL)
Mass-produced product of Collegium Pharmaceutical Inc

Earnings per share (EPS TTM) measures the ultimate efficiency of the business by allocating total annual income, net of all expenses, per common share. By analyzing the trailing twelve-month earnings per share, an investor assesses the ability of Collegium Pharmaceutical (COLL) to monetize its unique abuse-deterrent drug delivery system, which creates high market barriers for competitors.

Main competitors

INDV - Earnings per share for the last twelve months|Earnings per share for the trailing year CRON (thecronosgroup.com)|Canopy Growth Corporation (CGC) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months High Tide Inc|ACB (Aurora Cannabis, Inc.) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Achieve Life Sciences Inc (ACHV)|Earnings per share for the last twelve months Skye Bioscience (SKYE)|ANEB - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months InterCure INCR|Nutriband Inc - Earnings per share for the last twelve months|NSRX - Earnings per share for the last twelve months|IGC: Earnings per share for the last twelve months|MIRA: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months floragrowth.ca (FLGC)|IMCC (IM Cannabis Corp) - Net earnings per share (EPS TTM)|ADIL - Net earnings per share for the trailing year|Net earnings per share (EPS TTM) ARTL|Net earnings per share for the last four quarters ensysce.com|Titan Pharmaceuticals, Inc. - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) gnln.com GNLN|INM - Earnings per share for the last twelve months|Akanda Corp (AKAN) - Net earnings per share for the last 12 months|ENVB (Enveric) - Net earnings per share for the last 12 months|Bright Green Corporation - Earnings per share for the trailing year|Earnings per share for the last twelve months Hempacco Co., Inc.